Video Shorts

Why Rare Disease Developers Rely on PRVs

Does the FDA trust new NAM technology?

The 'Zero Nitrite' Myth in Pharma

New Parkinson's Breakthrough

Why One Good Supplier Isn't Enough to Fix Drug Shortages

Is Bio-Printing Organs Still a Fantasy?

Why We Have Drug Shortages and How to Fix Them

Can Organoids Replace Animal Testing?

Building Resilience in the Global Supply Chain

Is Your Company Risk-averse or Risk-tolerant

Why You Should Consider Pre-approval Submissions

Why AI Agents Need Regulatory Guardrails

Why You Need New Experts for AI Validation

Why Scanning Slides Isn't Enough

The Biggest Risk of AI in Documentation

The Hidden Risks of Scale-Up Manufacturing

Navigating the New EU Pharma Regulations

Major Shift in Biotech Manufacturing

Why Clinical Trial Strategy Needs Early Planning

Your AI Strategy is Your Data Strategy

How to Vet Importer of Record Partners for Clinical Trials

Reducing R&D Experiments by Orders of Magnitude with AI

The Cost of Customs Delays in Clinical Trials

Planning for Iteration in New Modality Manufacturing

How AI is Actually Changing Scientific Work

Moving Beyond 'Green' Talk in Pharma

Why Microstructure Intelligence Matters in Pharma

The Business Value of Attending CPHI

How CPHI is Evolving for 2026

De-risking Scale-up and Ensuring Regulatory Success